Coave Therapeutics (“Coave”), a company redefining targeted gene therapy with a best-in-class pipeline powered by ...
The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...
Aedes aegypti, commonly known as the yellow fever mosquito, is a highly adapted, invasive mosquito species recognized as a major global health threat that acts as the primary vector for several severe ...
Richland County will soon begin spraying for mosquitoes as part of the County’s annual effort to protect public health and ...
Boston)—Aedes aegypti, commonly known as the yellow fever mosquito, is a highly adapted, invasive mosquito species recognized as a major global ...
The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni ...
A prompt injection flaw in Google’s Antigravity IDE turns a file search tool into a remote code execution vector, bypassing ...
Immunofoco today announced the presentation of new preclinical data for its in vivo BCMA-targeting CAR-T candidate, IMV102, at the AACR Annual Meeting 2026. The data demonstrate that IMV102 achieved ...
A comprehensive overview of biosolids management, including federal regulations under the Clean Water Act, state laws like ...
PHOENIX — The CDC is reporting that ER visits for tick bites are higher than usual. The CDC says that, according to its Bite ...
The company’s forward price-to-earnings ratio of 29.69 reflects expectations for continued earnings expansion, supported by projected EPS growth of 41%. Revenue growth of 11% over the past year ...
Not nearly as polite as the name suggests, the ransomware gang has impressed researchers with its speed in scaling up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results